1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Bharat Book Logo

Europe Orphan Drug Market Outlook 2018

Bharatbook.com announces a new report on "Europe Orphan Drug Market Outlook 2018" which concept of rare diseases and the idea that a special attention needs to be given to this sector has been taking shape in Europe since the 1990s.

 
PRLog - Mar. 2, 2014 - NAVI MUMBAI, India -- Mar 03, 2014 : Bharat Book Bureau presents the new report, on 'Europe Orphan Drug Market Outlook 2018'. ever since then the political aspects and initiatives related to orphan medicinal products have been emerging at both the EU level and at the level of member states individually.

Many member states in the EU have led the way during the 1990s in the space of orphan medicinal products, the result of which took the shape of the first European legislative text concerning rare diseases called the Orphan Medicinal Product Regulation. This Regulation was adopted in 1999 and came into effect in 2000.

Europe is the second largest market for orphan drugs. In the European region, rare disease is considered to be a priority area and research in this field is given high importance by the EU Framework Programmes for Research and Technological Development (FP) ever since the early 1990s. Increasing the utilization of scarce resources and coordinating research efforts are the basic factors which have been responsible for success in the European rare diseases market. However, the absence of an exhaustive rare disease classification, standard terms of reference and a harmonized regulatory requirement, has always been a challenge in this region, which is currently impacting the global sharing of information, data and samples which would boost the research further.

The orphan drugs enjoy significant competitive advantages in the market owing to the market exclusivity period after the drug has been authorized. Through this clause, the manufacturer of orphan drugs is given a monopoly status in the market because according to the law, no other company is allowed to market the orphan drugs during the exclusivity period. Additionally, this monopolistic power is further strengthened with the fact that no other alternative health technology exists for many orphan drugs.

“Europe Orphan Drug Market Outlook (http://www.bharatbook.com/healthcare-market-research-repo...) 2018” research report by KuicK Research comprehensive insight on following developments related to Europe orphan drug market:

* Europe Orphan Drug Market Overview
*Orphan Drug Designation Criteria
* Market Specific Reimbursement Policy & Regulatory Framework
* Europe Orphan Drug Pipeline by Phase, Indication & Originator
* Marketed Orphan drug List by Indication & Brand Name
* Key Issue to be Addressed
* Competitive Landscape

Table of contents :

1. Introduction to Orphan Drugs
1.1 Orphan Drug Defined
1.2 Rising Popularity of Orphan Drugs

2. Why Shift from Non Orphan to Orphan Drugs?
2.1 Exhausting Product Pipelines
2.2 Profitability of Orphan Drugs
2.3 Increasing R&D Investment
2.4 Role of Economic Incentives
2.5 Patent Protection & Market Exclusivity

3. Europe Orphan Drug Market Outlook
3.1 Orphan Drug Designation Criteria
3.2 Market Overview
3.3 Europe Orphan Drug Reimbursement Policy

4. Europe Regulatory Framework for Orphan Drugs
4.1 Committee for Orphan Medicinal Products
4.2 How to Apply for Orphan Designation in Europe
4.3 Marketing Authorization & Market Exclusivity
4.4 Transferring An Orphan Designation To Another Sponsor
4.5 Mandatory Submission Of Annual Report On Development
4.6 Incentives For Micro, Small And Medium-Sized Enterprises
4.7 Fee Reductions For Designated Orphan Medicinal Products
4.8 Procedure for Orphan Designation & Incentives for R&D (Regulation (EC) No 141/2000)

5. Europe Orphan Drug Pipeline Insight by Phase & Indication
5.1 Preclinical
5.2 Phase I
5.3 Phase I/II
5.4 Phase II
5.5 Phase II/III
5.6 Phase III
5.7 Preregistration
5.8 Registration

For more information kindly visit : http://www.bharatbook.com/healthcare-market-research-reports-467719/europe-orphan-drug-market-outlook-2018.html

Related link :   http://www.bharatbook.com/market-research-report/pharmace...

About Bharat Book Bureau:

Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don't match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.

Contact us at :

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter:  https://twitter.com/researchbook
Follow us on linked in :  http://www.linkedin.com/company/bharat-book-bureau
Our Blog : http://blog.bharatbook.com/

Contact
Bharat Book Bureau
+91 22 27810772
***@bharatbook.com

--- End ---

Click to Share

Contact Email:
***@bharatbook.com
Source:Bharat Book Bureau
Location:Navi Mumbai - Maharashtra - India
Industry:Health
Tags:pharmaceuticals
Shortcut:prlog.org/12289681
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share